Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
---|---|---|---|---|---|---|
RYTM | RHYTHM PHARMACEUTICALS, INC. | Chief Financial Officer | $5.16 M | -$2.57 M | -33.3% | Mar 19, 2024 |
AGLE | Spyre Therapeutics, Inc. | Director | Jun 22, 2023 |
Sym | Company | Class | Transaction | % | Value $ | Price $ | Shares | Shares After | Date | Ownership |
---|